Where Discovery Begins
Luciferase Raji (CD20 KO) Cell Line
Cat. No.
GM-C40275
Size
2 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Related products
Specifications
Cat. No GM-C40275
Product Luciferase Raji (CD20 KO) Cell Line
Description Luciferase Raji (CD20 KO) Cell Line Cell Line is a clonal stable Raji (Human CD20 KO) cell line that constitutively expresses the Luciferase gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human CD20
Gene ID/Uniprot ID  
Host Cell Raji
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C40275
Product Luciferase Raji (CD20 KO) Cell Line
Description Luciferase Raji (CD20 KO) Cell Line Cell Line is a clonal stable Raji (Human CD20 KO) cell line that constitutively expresses the Luciferase gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human CD20
Gene ID/Uniprot ID  
Host Cell Raji
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
Luciferase Raji (CD20 KO) Cell Line (Cat. GM-C40275) was determined by flow cytometry using Anti-CD20 mIgG2a Antibody (Cat. GM-88845AB).
Correlation between the number of cells and bioluminescence values. Serial dilutions of Luciferase Raji (CD20 KO) Cell Line (Cat. GM-C40275) (96-well format). The firefly luciferase activity was measured using the GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit (Cat. GM-040513).
Genotype Verification
The Sanger sequencing of the Luciferase Raji (CD20 KO) Cell Line showed successful knockout of CD20.
Materials
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Anti-CD20 mIgG2a Antibody  Genomeditech/GM-88845AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Anti-CD20 mIgG2a Antibody  Genomeditech/GM-88845AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.2E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 2.5E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.2E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 2.5E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.

Related products
CD20(MS4A1)
H_CD20 KO RAMOS Cell Line ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Cynomolgus_CD20 CHO-K1 Cell line
H_CD20 CHO-K1 Cell Line H_CD20 HEK-293 Cell Line Mouse_CD20 CHO-K1 Cell Line
Anti-CD20 hIgG1 Reference Antibody (Ocrebio) Anti-CD20 hIgG1 Reference Antibody(Ritubio) Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio)
Anti-H_MS4A1(CD20) hIgG1 Antibody    
CD19
H_CD19 KO Raji Cell Line Cynomolgus_CD19 CHO-K1 Cell Line Cynomolgus_CD19 HEK-293 Cell Line
H_CD19 CHO-K1 Cell line H_CD19 HEK-293 Cell Line Mouse_CD19 CHO-K1 Cell Line
Anti-CD19 hIgG1 Reference Antibody (Loncbio) Anti-CD19×CD3 hIgG1 Antibody[PIT-565(CD58 K34A)] Anti-H_CD19 hIgG1/hIgG2 Antibody
CD3
Cynomolgus_CD3D CD3E Reporter Jurkat(CD3DE KO) Cell Line Jurkat CD3-BsAb Reporter Cell Line Cynomolgus_CD3 HEK-293 Cell Line
Cynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line H_CD3 CHO-K1 Cell Line H_CD3 HEK-293 Cell Line
H_CD3(TCR V2) CHO-K1 Cell Line H_CD3(TCR V2) HEK-293 Cell Line H_CD3(TCRαβ delta V) HEK-293 Cell Line
H_CD3D CD3E KO Jurkat Cell Line H_CD3E KO Jurkat Cell Line H_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line
Anti-CD19×CD3 hIgG1 Antibody[PIT-565(CD58 K34A)] Anti-CD3 epsilon hIgG1 Antibody [OKT-3 (muromonab)] Anti-CD3 hIgG1 Antibody(CH2527)
Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio) Anti-CD3×FCRL5 hIgG1 Bispecific Antibody Anti-CD3E×BCMA hIgG4 Reference Antibody (Tecbio)
Anti-CD3E×DLL3 hIgG1 Bispecific Antibody(Tarlabio) Anti-CD3E×MUC17 hIgG1 Bispecific Antibody(Vepsitbio) Anti-mouse CD3ε mIgG2a Antibody(145-2C11)
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Luciferase Raji (CD20 KO) Cell Line
Luciferase Raji (CD20 KO) Cell Line
Cat. No.
GM-C40275
Size
2 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Related products
Specifications
Cat. No GM-C40275
Product Luciferase Raji (CD20 KO) Cell Line
Description Luciferase Raji (CD20 KO) Cell Line Cell Line is a clonal stable Raji (Human CD20 KO) cell line that constitutively expresses the Luciferase gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human CD20
Gene ID/Uniprot ID  
Host Cell Raji
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C40275
Product Luciferase Raji (CD20 KO) Cell Line
Description Luciferase Raji (CD20 KO) Cell Line Cell Line is a clonal stable Raji (Human CD20 KO) cell line that constitutively expresses the Luciferase gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human CD20
Gene ID/Uniprot ID  
Host Cell Raji
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
Luciferase Raji (CD20 KO) Cell Line (Cat. GM-C40275) was determined by flow cytometry using Anti-CD20 mIgG2a Antibody (Cat. GM-88845AB).
Correlation between the number of cells and bioluminescence values. Serial dilutions of Luciferase Raji (CD20 KO) Cell Line (Cat. GM-C40275) (96-well format). The firefly luciferase activity was measured using the GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit (Cat. GM-040513).
Genotype Verification
The Sanger sequencing of the Luciferase Raji (CD20 KO) Cell Line showed successful knockout of CD20.
Materials
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Anti-CD20 mIgG2a Antibody  Genomeditech/GM-88845AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Anti-CD20 mIgG2a Antibody  Genomeditech/GM-88845AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.2E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 2.5E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into an appropriate culture flask and initially place the flask in an upright position after thawing.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+3 μg/mL Blasticidin+0.5 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.2E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 2.5E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.

Related products
CD20(MS4A1)
H_CD20 KO RAMOS Cell Line ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Cynomolgus_CD20 CHO-K1 Cell line
H_CD20 CHO-K1 Cell Line H_CD20 HEK-293 Cell Line Mouse_CD20 CHO-K1 Cell Line
Anti-CD20 hIgG1 Reference Antibody (Ocrebio) Anti-CD20 hIgG1 Reference Antibody(Ritubio) Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio)
Anti-H_MS4A1(CD20) hIgG1 Antibody    
CD19
H_CD19 KO Raji Cell Line Cynomolgus_CD19 CHO-K1 Cell Line Cynomolgus_CD19 HEK-293 Cell Line
H_CD19 CHO-K1 Cell line H_CD19 HEK-293 Cell Line Mouse_CD19 CHO-K1 Cell Line
Anti-CD19 hIgG1 Reference Antibody (Loncbio) Anti-CD19×CD3 hIgG1 Antibody[PIT-565(CD58 K34A)] Anti-H_CD19 hIgG1/hIgG2 Antibody
CD3
Cynomolgus_CD3D CD3E Reporter Jurkat(CD3DE KO) Cell Line Jurkat CD3-BsAb Reporter Cell Line Cynomolgus_CD3 HEK-293 Cell Line
Cynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line H_CD3 CHO-K1 Cell Line H_CD3 HEK-293 Cell Line
H_CD3(TCR V2) CHO-K1 Cell Line H_CD3(TCR V2) HEK-293 Cell Line H_CD3(TCRαβ delta V) HEK-293 Cell Line
H_CD3D CD3E KO Jurkat Cell Line H_CD3E KO Jurkat Cell Line H_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line
Anti-CD19×CD3 hIgG1 Antibody[PIT-565(CD58 K34A)] Anti-CD3 epsilon hIgG1 Antibody [OKT-3 (muromonab)] Anti-CD3 hIgG1 Antibody(CH2527)
Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio) Anti-CD3×FCRL5 hIgG1 Bispecific Antibody Anti-CD3E×BCMA hIgG4 Reference Antibody (Tecbio)
Anti-CD3E×DLL3 hIgG1 Bispecific Antibody(Tarlabio) Anti-CD3E×MUC17 hIgG1 Bispecific Antibody(Vepsitbio) Anti-mouse CD3ε mIgG2a Antibody(145-2C11)
Contact
Us
Message Inquiry
reset
submit
Message
Message Inquiry
reset
submit